INmune Bio
INMB
INMB
51 hedge funds and large institutions have $32.2M invested in INmune Bio in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 47 → 51 (+4)
2.41% more ownership
Funds ownership: 12.79% → 15.2% (+2.4%)
Holders
51
Holding in Top 10
–
Calls
$653K
Puts
$44K
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.3M | |
| 3 | +$1.03M | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$980K |
| 5 |
Jane Street
New York
|
+$362K |
Top Sellers
| 1 | -$676K | |
| 2 | -$398K | |
| 3 | -$266K | |
| 4 |
6CM
683 Capital Management
New York
|
-$217K |
| 5 |
BlackRock
New York
|
-$209K |